Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. In Vivo Detection of miRNA Expression in Tumors Using an Activatable Nanosensor

In Vivo Detection of miRNA Expression in Tumors Using an Activatable Nanosensor

Thumbnail Image
Download
Name

11307_2015_Article_863.pdf

Size

3.17 MB

Format

Adobe PDF

Checksum (MD5)

57276927ea409e0ca251e0c2b17846c8

Download all files submitted through automated deposit
art_5561419469253163346.zip (3.09 MB)
Author(s)
Yoo, Byunghee
•
Kavishwar, Amol
•
Ross, Alana
•
Pantazopoulos, Pamela
•
Moore, Anna
•
Medarova, Zdravka
Date Issued
May 2015
Journal
Molecular Imaging and Biology
Publisher
Springer US
Citation
Yoo, Byunghee et al. “In Vivo Detection of miRNA Expression in Tumors Using an Activatable Nanosensor.” Molecular Imaging and Biology 18.1 (2016): 70–78.
Version
Author's final manuscript
Abstract
Purpose The development of tools for the analysis of microRNA (miRNA) function in tumors can advance our diagnostic and prognostic capabilities. Here, we describe the development of technology for the profiling of miRNA expression in the tumors of live animals. Procedures The approach is based on miRNA nanosensors consisting of sensor oligonucleotides conjugated to magnetic nanoparticles for systemic delivery. Feasibility was demonstrated for the detection of miR-10b, implicated in epithelial to mesenchymal transition and the development of metastasis. The miR-10b nanosensor was tested in vivo in two mouse models of cancer. In the first model, mice were implanted subcutaneously with MDA-MB-231-luc-D3H2LN tumors, in which miR-10b was inhibited. In the second model, mice were implanted bilaterally with metastatic MDA-MB-231 and nonmetastatic MCF-7 cells. The nanosensors were injected intravenously, and fluorescence intensity in the tumors was monitored over time. Results We showed that the described nanosensors are capable of discriminating between tumors based on their expression of miR-10b. Radiant efficiency was higher in the miR-10b-active tumors than in the miR-10b-inhibited tumors and in the MDA-MB-231 tumors relative to the MCF-7 tumors. Conclusions The described technology provides an important tool that could be used to answer questions about microRNA function in cancer.
MIT Department
Martinos Imaging Center (McGovern Institute for Brain Research at MIT)
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
http://hdl.handle.net/1721.1/105229
DOI of Published Version
https://doi.org/10.1007/s11307-015-0863-3
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.